These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 7481534)

  • 21. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
    Papo M; Quer JC; Pastor RM; García-Pardo G; Olona M; Prats E; Mirapeix E; Rodríguez R; Richart C
    Med Clin (Barc); 1998 Jan; 110(1):11-5. PubMed ID: 9527980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value.
    Olives JP; Breton A; Hugot JP; Oksman F; Johannet C; Ghisolfi J; Navarro J; Cézard JP
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):142-8. PubMed ID: 9252899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-neutrophil cytoplasmic antibodies (ANCA) and inflammatory bowel diseases in Chinese.
    Sung JY; Chan FK; Lawton J; Leung JC; Liew CT; Leung NW; Hsu R; Lai KN
    Dig Dis Sci; 1994 Apr; 39(4):886-92. PubMed ID: 8149855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease].
    García-Herola A; Nos P; Hoyos M; Hinojosa J; Molés JR; Pascual S; Bustamante M; Sánchez Cuenca JM; Carmona E; Ponce J; Berenguer J
    Gastroenterol Hepatol; 1998 Apr; 21(4):169-73. PubMed ID: 9633176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
    Halbwachs-Mecarelli L; Nusbaum P; Noël LH; Reumaux D; Erlinger S; Grünfeld JP; Lesavre P
    Clin Exp Immunol; 1992 Oct; 90(1):79-84. PubMed ID: 1327593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity.
    Broekroelofs J; Mulder AH; Nelis GF; Westerveld BD; Tervaert JW; Kallenberg CG
    Dig Dis Sci; 1994 Mar; 39(3):545-9. PubMed ID: 7510606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
    Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p-ANCA target antigens in ulcerative colitis.
    Folwaczny C; Jochum M; Noehl N; Schnettler D; Loeschke K; Fricke H
    Z Gastroenterol; 1998 Aug; 36(8):625-33. PubMed ID: 9773480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.
    Sandborn WJ; Loftus EV; Colombel JF; Fleming KA; Seibold F; Homburger HA; Sendid B; Chapman RW; Tremaine WJ; Kaul DK; Wallace J; Harmsen WS; Zinsmeister AR; Targan SR
    Inflamm Bowel Dis; 2001 Aug; 7(3):192-201. PubMed ID: 11515844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
    Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B
    Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease.
    Proujansky R; Fawcett PT; Gibney KM; Treem WR; Hyams JS
    J Pediatr Gastroenterol Nutr; 1993 Aug; 17(2):193-7. PubMed ID: 8229547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease.
    Saxon A; Shanahan F; Landers C; Ganz T; Targan S
    J Allergy Clin Immunol; 1990 Aug; 86(2):202-10. PubMed ID: 2200820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity.
    Abad E; Tural C; Mirapeix E; Cuxart A
    J Autoimmun; 1997 Apr; 10(2):175-80. PubMed ID: 9185879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens.
    Vecchi M; Bianchi MB; Sinico RA; Radice A; Meucci G; Torgano G; Omodei P; Forzenigo L; Landoni M; Arrigoni M
    Digestion; 1994; 55(1):34-9. PubMed ID: 8112495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of neutrophil autoantibodies in 500 consecutive patients with inflammatory bowel disease.
    Freeman H; Roeck B; Devine D; Carter C
    Can J Gastroenterol; 1997 Apr; 11(3):203-7. PubMed ID: 9167026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
    Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
    J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Papp M; Altorjay I; Lakos G; Tumpek J; Sipka S; Dinya T; Palatka K; Veres G; Udvardy M; Lakatos PL
    Clin Vaccine Immunol; 2009 Apr; 16(4):464-70. PubMed ID: 19193830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease.
    Cabral VL; Miszputen SJ; Catapani WR
    Hepatogastroenterology; 2003; 50(50):412-5. PubMed ID: 12749235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?
    Seibold F; Weber P; Schöning A; Mörk H; Goppel S; Scheurlen M
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1095-100. PubMed ID: 8944372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.